World Library  
Flag as Inappropriate
Email this Article

GABA receptor

Article Id: WHEBN0000737618
Reproduction Date:

Title: GABA receptor  
Author: World Heritage Encyclopedia
Language: English
Subject: Idiopathic generalized epilepsy, Ion channel, Ionotropic receptors, Mesolimbic pathway, Thiomuscimol
Collection: G Protein Coupled Receptors, Ionotropic Receptors
Publisher: World Heritage Encyclopedia

GABA receptor

The GABA receptors are a class of receptors that respond to the neurotransmitter gamma-aminobutyric acid (GABA), the chief inhibitory neurotransmitter in the mature vertebrate central nervous system. There are two classes of GABA receptors: GABAA and GABAB.

GABAA receptors are ligand-gated ion channels (also known as ionotropic receptors), whereas GABAB receptors are G protein-coupled receptors (also known as metabotropic receptors).


  • Ligand-gated ion channels: GABAA 1
    • GABAA-ρ subclass (formerly GABAC) 1.1
  • G protein coupled receptor: GABAB 2
  • Other receptors 3
  • See also 4
  • References 5
  • External links 6

Ligand-gated ion channels: GABAA

It has long been recognized that the fast response of neurons to GABA that is blocked by bicuculline and picrotoxin is due to direct activation of an anion channel.[1][2][3][4][5] This channel was subsequently termed the GABAA receptor.[6] Fast-responding GABA receptors are members of family of Cys-loop ligand-gated ion channels.[7][8][9] Members of this superfamily, which includes nicotinic acetylcholine receptors, GABAA receptors, glycine and 5-HT3 receptors, possess a characteristic loop formed by a disulfide bond between two cysteine residues.

In ionotropic GABAA receptors, binding of GABA molecules to their binding sites in the extracellular part of the receptor triggers opening of a chloride ion-selective pore. The increased chloride conductance drives the membrane potential towards the reversal potential of the Cl¯ ion which is about –65 mV in neurons, inhibiting the firing of new action potentials. This mechanism is responsible for the sedative effects of GABAA allosteric agonists.

However, there are numerous reports of excitatory GABAA receptors. This phenomenon is due to increased intracellular concentration of Cl¯ ions either during development of the nervous system[10][11] or in certain cell populations.[12][13][14]

After this period of development, a chloride pump is upregulated and inserted into the cell membrane, pumping Cl ions into the extracellular space of the tissue. Further openings via GABA binding to the receptor then produce inhibitory responses. Over-excitation of this receptor induces receptor remodeling and the eventual invagination of the GABA receptor. As a result, further GABA binding becomes inhibited and IPSPs are no longer relevant.

GABAA-ρ subclass (formerly GABAC)

A subclass of ionotropic GABA receptors, insensitive to typical allosteric modulators of GABAA receptor channels such as benzodiazepines and barbiturates,[15][16][17] was designated GABAС receptor.[18][19] Native responses of the GABAC receptor type occur in retinal bipolar or horizontal cells across vertebrate species.[20][21][22][23]

GABAС receptors are exclusively composed of ρ (rho) subunits that are related to GABAA receptor subunits.[24][25][26] Although the term "GABAС receptor" is frequently used, GABAС may be viewed as a variant within the GABAA receptor family.[7] Others have argued that the differences between GABAС and GABAA receptors are large enough to justify maintaining the distinction between these two subclasses of GABA receptors.[27][28] However since GABAС receptors are closely related in sequence, structure, and function to GABAA receptors and since other GABAA receptors besides those containing ρ subunits appear to exhibit GABAС pharmacology, the Nomenclature Committee of the IUPHAR has recommended that the GABAС term no longer be used and these ρ receptors should be designated as the ρ subfamily of the GABAA receptors (GABAA-ρ).[29]

G protein coupled receptor: GABAB

A slow response to GABA is mediated by GABAB receptors,[30] originally defined on the basis of pharmacological properties.[31]

In studies focused on the control of neurotransmitter release, it was noted that a GABA receptor was responsible for modulating evoked release in a variety of isolated tissue preparations. This ability of GABA to inhibit neurotransmitter release from these preparations was not blocked by bicuculline, was not mimicked by isoguvacine, and was not dependent on Cl¯, all of which are characteristic of the GABAA receptor. The most striking discovery was the finding that baclofen (β-parachlorophenyl GABA), a clinically employed spasmolytic[32][33] mimicked, in a stereoselective manner, the effect of GABA.

Later ligand-binding studies provided direct evidence of binding sites for baclofen on central neuronal membranes.[34] cDNA cloning confirmed that the GABAB receptor belongs to the family of G-protein coupled receptors.[35] Additional information on GABAB receptors has been reviewed elsewhere.[36][37][38][39][40][41][42][43]

Other receptors

This has a parallel to several other receptors in the body, in which a single molecule binds to receptors which function in completely different ways:

See also


  1. ^ Kuffler SW, Edwards C (November 1958). "Mechanism of gamma aminobutyric acid (GABA) action and its relation to synaptic inhibition". J. Neurophysiol. 21 (6): 589–610.  
  2. ^ Kravitz EA, Kuffler SW, Potter DD (September 1963). "Gamma-aminobutyric acid and other blocking compounds in crustacea. III. Their relative concentrations in separated motor and inhibitory axons". J. Neurophysiol. 26: 739–51.  
  3. ^ Krnjević K, Schwartz S (1967). "The action of gamma-aminobutyric acid on cortical neurones". Exp Brain Res 3 (4): 320–36.  
  4. ^ Takeuchi A, Takeuchi N (August 1967). "Anion permeability of the inhibitory post-synaptic membrane of the crayfish neuromuscular junction". J. Physiol. (Lond.) 191 (3): 575–90.  
  5. ^ Takeuchi A, Takeuchi N (November 1969). "A study of the action of picrotoxin on the inhibitory neuromuscular junction of the crayfish". J. Physiol. (Lond.) 205 (2): 377–91.  
  6. ^ Takeuchi A, Onodera K (March 1972). "Effect of bicuculline on the GABA receptor of the crayfish neuromuscular junction". Nature New Biol. 236 (63): 55–6.  
  7. ^ a b Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup C, Bateson AN, Langer SZ (June 1998). "International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function".  
  8. ^ Hevers W, Lüddens H (August 1998). "The diversity of GABAA receptors. Pharmapoo and electrophysiological properties of GABAA channel subtypes". Mol. Neurobiol. 18 (1): 35–86.  
  9. ^ Sieghart W, Sperk G (August 2002). "Subunit composition, distribution and function of GABA(A) receptor subtypes". Curr Top Med Chem 2 (8): 795–816.  
  10. ^ Ben-Ari Y, Khazipov R, Leinekugel X, Caillard O, Gaiarsa JL (November 1997). "GABAA, NMDA and AMPA receptors: a developmentally regulated 'ménage à trois'". Trends Neurosci. 20 (11): 523–9.  
  11. ^ Taketo M, Yoshioka T (2000). "Developmental change of GABA(A) receptor-mediated current in rat hippocampus". Neuroscience 96 (3): 507–14.  
  12. ^ Tomiko SA, Taraskevich PS, Douglas WW (February 1983). "GABA acts directly on cells of pituitary pars intermedia to alter hormone output". Nature 301 (5902): 706–7.  
  13. ^ Cherubini E, Gaiarsa JL, Ben-Ari Y (December 1991). "GABA: an excitatory transmitter in early postnatal life". Trends Neurosci. 14 (12): 515–9.  
  14. ^ Lamsa K, Taira T (September 2003). "Use-dependent shift from inhibitory to excitatory GABAA receptor action in SP-O interneurons in the rat hippocampal CA3 area". J. Neurophysiol. 90 (3): 1983–95.  
  15. ^ Sivilotti L, Nistri A (1991). "GABA receptor mechanisms in the central nervous system". Prog. Neurobiol. 36 (1): 35–92.  
  16. ^ Bormann J, Feigenspan A (December 1995). "GABAC receptors". Trends Neurosci. 18 (12): 515–9.  
  17. ^ Johnston GA (September 1996). "GABAc receptors: relatively simple transmitter -gated ion channels?". Trends Pharmacol. Sci. 17 (9): 319–23.  
  18. ^ Drew CA, Johnston GA, Weatherby RP (December 1984). "Bicuculline-insensitive GABA receptors: studies on the binding of (-)-baclofen to rat cerebellar membranes". Neurosci. Lett. 52 (3): 317–21.  
  19. ^ Zhang D, Pan ZH, Awobuluyi M, Lipton SA (March 2001). "Structure and function of GABA(C) receptors: a comparison of native versus recombinant receptors". Trends Pharmacol. Sci. 22 (3): 121–32.  
  20. ^ Feigenspan A, Wässle H, Bormann J (January 1993). "Pharmacology of GABA receptor Cl- channels in rat retinal bipolar cells". Nature 361 (6408): 159–62.  
  21. ^ Qian H, Dowling JE (January 1993). "Novel GABA responses from rod-driven retinal horizontal cells". Nature 361 (6408): 162–4.  
  22. ^ Lukasiewicz PD (June 1996). "GABAC receptors in the vertebrate retina". Mol. Neurobiol. 12 (3): 181–94.  
  23. ^ Wegelius K, Pasternack M, Hiltunen JO, Rivera C, Kaila K, Saarma M, Reeben M (January 1998). "Distribution of GABA receptor rho subunit transcripts in the rat brain". Eur. J. Neurosci. 10 (1): 350–7.  
  24. ^ Shimada S, Cutting G, Uhl GR (April 1992). "gamma-Aminobutyric acid A or C receptor? gamma-Aminobutyric acid rho 1 receptor RNA induces bicuculline-, barbiturate-, and benzodiazepine-insensitive gamma-aminobutyric acid responses in Xenopus oocytes". Mol. Pharmacol. 41 (4): 683–7.  
  25. ^ Kusama T, Spivak CE, Whiting P, Dawson VL, Schaeffer JC, Uhl GR (May 1993). "Pharmacology of GABA rho 1 and GABA alpha/beta receptors expressed in Xenopus oocytes and COS cells". Br. J. Pharmacol. 109 (1): 200–6.  
  26. ^ Kusama T, Wang TL, Guggino WB, Cutting GR, Uhl GR (March 1993). "GABA rho 2 receptor pharmacological profile: GABA recognition site similarities to rho 1". Eur. J. Pharmacol. 245 (1): 83–4.  
  27. ^ Chebib M, Johnston GA (April 2000). "GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology". J. Med. Chem. 43 (8): 1427–47.  
  28. ^ Bormann J (January 2000). "The 'ABC' of GABA receptors". Trends Pharmacol. Sci. 21 (1): 16–9.  
  29. ^ Olsen RW, Sieghart W (September 2008). "International Union of Pharmacology. LXX. Subtypes of γ-Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Composition, Pharmacology, and Function. Update". Pharmacological Reviews 60 (3): 243–60.  
  30. ^ Bowery NG, Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M, Bonner TI, Enna SJ (June 2002). "International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function". Pharmacological Reviews 54 (2): 247–64.  
  31. ^ Bowery NG, Hill DR, Hudson AL, Doble A, Middlemiss DN, Shaw J, Turnbull M (January 1980). "(-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor". Nature 283 (5742): 92–4.  
  32. ^ Bein HJ (1972). "Pharmacological differentiations of muscle relaxants". In Birkmayer W. Spasticity: A Topical Survey. Hans Hubert Bern, Switzerland. pp. 76–89.  
  33. ^ Keberle H, Faigle JW (1972). "Synthesis and structure-activity relationship of the gamma-aminobutyric acid derivatives". In Birkmayer W. Spasticity: A Topical Survey. Hans Hubert Bern, Switzerland. pp. 76–89.  
  34. ^ Hill DR, Bowery NG (March 1981). "3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA B sites in rat brain". Nature 290 (5802): 149–52.  
  35. ^ Kaupmann K, Huggel K, Heid J, Flor PJ, Bischoff S, Mickel SJ, McMaster G, Angst C, Bittiger H, Froestl W, Bettler B (March 1997). "Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors". Nature 386 (6622): 239–46.  
  36. ^ Enna SJ (October 1997). "GABAB receptor agonists and antagonists: pharmacological properties and therapeutic possibilities". Expert Opin Investig Drugs 6 (10): 1319–25.  
  37. ^ Bowery, N. G.; Enna, S. J. (1997). The GABA receptors. Totowa, NJ: Humana Press.  
  38. ^ Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, Mosbacher J, Bischoff S, Kulik A, Shigemoto R, Karschin A, Bettler B (December 1998). "GABA(B)-receptor subtypes assemble into functional heteromeric complexes". Nature 396 (6712): 683–7.  
  39. ^ Kaupmann K, Schuler V, Mosbacher J, Bischoff S, Bittiger H, Heid J, Froestl W, Leonhard S, Pfaff T, Karschin A, Bettler B (December 1998). "Human γ-aminobutyric acid type B receptors are differentially expressed and regulate inwardly rectifying K+ channels". Proc. Natl. Acad. Sci. U.S.A. 95 (25): 14991–6.  
  40. ^ Marshall FH, Jones KA, Kaupmann K, Bettler B (October 1999). "GABAB receptors - the first 7TM heterodimers". Trends Pharmacol. Sci. 20 (10): 396–9.  
  41. ^ Marshall FH, White J, Main M, Green A, Wise A (August 1999). "GABA(B) receptors function as heterodimers". Biochem. Soc. Trans. 27 (4): 530–5.  
  42. ^ Bowery NG, Enna SJ (January 2000). "gamma-aminobutyric acid(B) receptors: first of the functional metabotropic heterodimers". J. Pharmacol. Exp. Ther. 292 (1): 2–7.  
  43. ^ Enna SJ (2001). "GABAB receptor signaling pathways". In Möhler H. Pharmacology of GABA and Glycine Neurotransmission (Handbook of Experimental Pharmacology) (Volume 150). Berlin: Springer. pp. 329–342.  

External links

  • receptorsBIUPHAR GPCR Database - GABA
  • GABA Receptor at the US National Library of Medicine Medical Subject Headings (MeSH)
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.